Candesic advised on the acquisition and investment of Aesthetic Technology by Omni Partners By Candesic Ltd

Candesic advised on the acquisition and investment of Aesthetic Technology Ltd by Omni Partners LLP. 

We are proud to share our support on this deal that will accelerate ATL’s international expansion and product development into further medical treatment pathways. 

About

Candesic is a leading strategy consultancy head-quartered in London, serving private operators, investors, and public sector organisations.

Privacy

Privacy Policy

News & Publications

Candesic proudly advised on Kester Capital investment
Candesic proudly advised on Kester Capital fifth investment in the life sciences sector into MAP Patient Access Limited, a specialist in market access consulting services to the pharmaceutical and biotech sectors. The mission of MAP Patient Access Limited is to make it easier for patients to access ground-breaking medicines, devices, and diagnostics. In addition to its expertise in rare and orphan diseases, it has a proven track record of helping its clients navigate increasingly complex healthcare reimbursement pathways.

HealthTechX Global 2023 was quite the event!
Thanks to all HealthTechX Global 2023- it was quite the event!

Candesic visits Imperial College Business School ‎
This week our team visited Imperial College Business School. **Candesic** is a leading strategy consultancy providing CEO level clarity with R&D level insights for over 21 years.

© Candesic 2023